Welcome Guest to Happi

Subscribe Free: Magazine | eNewsletter

current issue May 2015
 •  Palmers Casts Hewitt for Fall Campaign  •  UPDATE: P&G Sells Frédéric Fekkai  •  Novex Expands With Curls Collection  •  Net-A-Porter Picks Up Goldfaden MD  •  Spectrum Buys Armor All
Print

Dermatology Drug Market To Grow 8% a Year to 2008



Published November 22, 2005
Related Searches: dermatology food men gel
Post a comment
The Dermatology Drug market will grow 8% a year to 2008, led by demand for psoriasis treatments, according to the “Dermatology pipeline analysis: a market with room to grow” report by Decision Resources (DR), Waltham, MA. This is largely due to the Food and Drug Administration’s approval of Enbrel, an Amgen-based treatment for adults with moderate-to-severe chronic plaque psoriasis. Medications for atopic dermatitis will also increase, but uticario medications will decline.


blog comments powered by Disqus